ライフサイエンスコーパス: fetal calf

1 more nonprotein, low m.w. factors present in fetal calf and mouse sera.

2 ll-thickness cartilage during bovine growth (fetal, calf, and adult) and human adult aging (young and

3 light causes inactivation of GR in human and fetal calf lenses under both anaerobic and aerobic condi

4 f tropoelastin secretion was investigated in fetal calf ligamentum nuchae (FCL) cells using brefeldin

5 ed some scholars to suggest that the skin of fetal calves or sheep was used.

6 f V lambda sequences in late first-trimester fetal calves revealed that diversity appears in the earl

7 neonatal mouse calvariae, and cultured with fetal calf serum (10% for osteoblast-like cells and 2% f

8 aqueous buffer (PBS) or in media containing fetal calf serum (10%), is rapidly taken-up into culture

9 Fetal calf serum (10%)- and PDGF (10 ng/mL)-stimulated i

10 4 versus 19 +/- 6%, P = 0.01) as well as 10% fetal calf serum (19 +/- 7 versus 31 +/- 6%, P = 0.03).

11 26695 cultured in brucella broth containing fetal calf serum (BBF) alone or supplemented with 100 mi

12 growth was measured after 3 to 7 days in 1% fetal calf serum (FCS) + RPMI 1640.

13 Fetal calf serum (FCS) and bone morphogenetic proteins (

14 reduced by stimulation of proliferation with fetal calf serum (FCS) and platelet-derived growth facto

15 sCD44 was isolated from human or fetal calf serum (FCS) by urea solubilization and immuno

16 ltured in modified Ham's F10 medium with 10% fetal calf serum (FCS) for 10 days.

17 se dependent and affected by the presence of fetal calf serum (FCS) in the growth medium.

18 d to culture medium supplemented with 1) 15% fetal calf serum (FCS) only; 2) 1% FCS only; 3) 1% FCS a

19 s stimulated over 50-fold by the addition of fetal calf serum (FCS) to the cell culture medium (RPMI

20 Human TM cells grown in 10% fetal calf serum (FCS) were incubated in 0.1% FCS with 1

21 e medium (minimum essential medium, MEM) and fetal calf serum (FCS) were probed by XANES and EXAFS.

22 HAVSMCs stimulated with fetal calf serum (FCS) were pulsed with bromodeoxyuridin

23 parent deficiency and identified a factor in fetal calf serum (FCS) which is capable of mediating upt

24 were cultured in medium supplemented with 5% fetal calf serum (FCS), anti-CD3 antibody, and interleuk

25 n media containing various concentrations of fetal calf serum (FCS), bovine serum albumin, or porcine

26 rates as control cells when cultured in 0.5% fetal calf serum (FCS), but failed to undergo fetal calf

27 When exposed to 10% fetal calf serum (FCS), there were no differences in gro

28 ured with adherent cells (macrophages) in 1% fetal calf serum (FCS)- or adult mouse serum (AMS)-suppl

29 telencephalic cells cultured in 0.5 or 2.0% fetal calf serum (FCS)-containing medium for 48 hr showe

30 nist concentration-dependent potentiation of fetal calf serum (FCS)-stimulated cell proliferation.

31 etal calf serum (FCS), but failed to undergo fetal calf serum (FCS)-stimulated hyperplasia when grown

32 n culture using medium supplemented with 10% fetal calf serum (FCS).

33 microL TGF-beta2 (TGF-beta2-treated group), fetal calf serum (FCS)/phosphate-buffered saline (PBS; F

34 resence of cytokines and 5% heat-inactivated fetal calf serum (HI-FCS).

35 transcriptase as well as their stability in fetal calf serum and in CEM cell extracts.

36 le's minimal essential media (EMEM) with 10% fetal calf serum and Pluronic F-68 or F-127 in concentra

37 Estrogen levels present in fetal calf serum are sufficient to maintain AIB1 mRNA an

38 on in RPMI 1640 medium supplemented with 15% fetal calf serum at 37 degrees C with 5% CO(2) in air.

39 ss-galactosidase, bovine serum albumin, nor fetal calf serum caused an increase in outflow resistanc

40 Response of cells to stimulation by fetal calf serum could be reproduced by the model, furth

41 Charcoal filtration of fetal calf serum eliminated the block of PPARgamma, wher

42 Fetal calf serum enhanced the stimulatory effect of over

43 Cells cultured in 10% dialyzed fetal calf serum exhibited decreased synthesis of more h

44 odified Eagle's medium supplemented with 10% fetal calf serum for up to four passages.

45 Exposure to fetal calf serum induces GRP cells to differentiate into

46 forming growth factor beta-1 (TGF-beta1) and fetal calf serum on proteoglycan synthesis in corneal fi

47 ific developmental stage and the presence of fetal calf serum or a larval extract in the medium.

48 % +/- 12% 48 hours after incubation with 10% fetal calf serum or epidermal growth factor (5 ng/mL), r

49 -steroidal ecdysone analog RH5992 for either fetal calf serum or larval extract also results in activ

50 fetal cultures grown in the presence of 2.5% fetal calf serum than in that grown with 15% fetal calf

51 tion as well as the individual proteins from fetal calf serum that are associated with lipoplexes.

52 tion efficiency of the stable complex in 15% fetal calf serum was 30% of that obtained in the absence

53 When fetal calf serum was included in cartilage cultures, MMP

54 Cell proliferation in response to fetal calf serum was later determined in the presence an

55 ells are grown in low serum conditions (0.1% fetal calf serum) and is observed selectively with trans

56 urrently used clinically (but which contains fetal calf serum), and a serum-free alternative, M2 (mel

57 mbryonic MM cell line (or, similarly, by 10% fetal calf serum), forms branching tubules under three-d

58 -12 medium containing 2 x amino acids and 5% fetal calf serum).

59 ed Eagle's medium, nonessential amino acids, fetal calf serum, and beta-mercaptoethanol.

60 after stimulation by lysophosphatidic acid, fetal calf serum, and epidermal growth factor retain act

61 media, cytokines, growth factors, hormones, fetal calf serum, and serum extracts.

62 The effect of gamma interferon, fetal calf serum, and the recombination proficiency of E

63 s with 12-O-tetradecanoylphorbol-13-acetate, fetal calf serum, anisomycin, UV irradiation, tumor necr

64 ifically in response to IGF-I but not to 10% fetal calf serum, epidermal growth factor, fibroblast gr

65 Growth factors such as fetal calf serum, epidermal growth factor, phorbol 12-my

66 te in Dulbecco's modified Eagle's medium and fetal calf serum, even with supplemental growth factors.

67 f NPCCs was achieved in vitro by addition of fetal calf serum, insulin-like growth factor-I, nicotina

68 A combination of fetal calf serum, insulin-like growth factor-I, nicotina

69 leukin-1, platelet-derived growth factor, or fetal calf serum, MCs initiated rapid HA synthesis assoc

70 fetal calf serum than in that grown with 15% fetal calf serum, suggesting that factors present in the

71 ee medium (SFM) or SFM supplemented with 10% fetal calf serum, TGF-gamma1, TGF-beta2, TGF-beta3, basi

72 Dulbecco's minimal essential medium plus 10% fetal calf serum, were added to new wounds.

73 ring glomerular injury, the effect of PF4 on fetal calf serum- and platelet-derived growth factor (PD

74 of cell-based therapies using cells grown in fetal calf serum-containing media, an antibody response

75 nergistic effect of Tpo was observed both in fetal calf serum-supplemented and serum-depleted medium

76 ted at a concentration of 1 cell per well in fetal calf serum-supplemented and serum-depleted medium.

77 n both LPS-treated RAW 264.7 macrophages and fetal calf serum-treated mouse embryonic fibroblasts, TT

78 presence of tissue culture medium containing fetal calf serum.

79 lls cultured in growth medium containing 10% fetal calf serum.

80 cing agent hydrogen peroxide and slightly by fetal calf serum.

81 elet-derived growth factor BB and 2% or less fetal calf serum.

82 st of these dissolves without aggregation in fetal calf serum.

83 eration of WI38 cells in the presence of 10% fetal calf serum.

84 r DMEM media with or without pyruvate and 1% fetal calf serum.

85 without trypsin in the presence of 5 to 10% fetal calf serum.

86 compared with cells cultured in 1% dialyzed fetal calf serum.

87 ted with either 50% autologous plasma or 10% fetal calf serum.

88 d in essential modified Eagle's medium + 10% fetal calf serum.

89 ascites fluid, and to remove bovine IgG from fetal calf serum.

90 hosphate-buffered saline (PBS) buffer and in fetal calf serum.

91 Dulbecco's modified Eagle's medium with 10% fetal calf serum.

92 astrocytic cell phenotype in the presence of fetal calf serum.

93 EMEM) alone or in EMEM supplemented with 10% fetal calf serum.

94 venom phosphodiesterase, S1 nuclease and in fetal calf serum.

95 t complex was completely inactivated with 2% fetal calf serum.

96 to 24/36-mer primer/template DNA by purified fetal calf thymus DNA polymerase (pol) delta was examine

97 pposite 8-oxo-7,8-dihydroguanine (8-oxoG) by fetal calf thymus DNA polymerase delta (pol delta) was e

98 Fetal calf thymus extracts were chromatographed on PCNA-

99 rodimeric DNA polymerase delta isolated from fetal calf thymus, and the enzymes were found to differ